Cesar Seigi Fuziwara (Cesar S Fuziwara)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 11

Top Venues

International journal of molecular sciences

Cells

Archives of endocrinology and metabolism

Cancers

Universidade de Sao Paulo Instituto de Ciencias Biomedicas (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Universidade de Sao Paulo Instituto de Ciencias Biomedicas Sep 01 2010 - Sep 01 2014

Brazil

PHD :: Biologia Celular e do Desenvolvimento

Publications

Letícia F Alves, Isabelle N da Silva, Diego Claro de Mello, Cesar Seigi Fuziwara, Sonia Guil, Manel Esteller, Murilo V Geraldo
Epigenetic Regulation of DLK1-DIO3 Region in Thyroid Carcinoma. Cells 13 (12) (2024)
Letícia F Alves, Isabelle N da Silva, Diego Claro de Mello, Cesar Seigi Fuziwara, Sonia Guil, Manel Esteller, Murilo V Geraldo
Epigenetic Regulation of DLK1-DIO3 Region in Thyroid Carcinoma. Cells 13 (12) (2024)
Diego Claro de Mello, Kelly Cristina Saito, Marcella Maringolo Cristovão, Edna Teruko Kimura, Cesar Seigi Fuziwara
Modulation of EZH2 Activity Induces an Antitumoral Effect and Cell Redifferentiation in Anaplastic Thyroid Cancer. International journal of molecular sciences 24 (9) (2023)
Diego Claro de Mello, Kelly Cristina Saito, Marcella Maringolo Cristovão, Edna Teruko Kimura, Cesar Seigi Fuziwara
Modulation of EZH2 Activity Induces an Antitumoral Effect and Cell Redifferentiation in Anaplastic Thyroid Cancer. International journal of molecular sciences 24 (9) (2023)
Diego Claro de Mello, Kelly Cristina Saito, Marcella Maringolo Cristovão, Edna Teruko Kimura, Cesar Seigi Fuziwara
Modulation of EZH2 Activity Induces an Antitumoral Effect and Cell Redifferentiation in Anaplastic Thyroid Cancer. International journal of molecular sciences 24 (9) (2023)
Maria Gabriela Pereira Dos Santos, Guilherme Henrique Gatti da Silva, Helder Yudi Nagasse, Cesar Seigi Fuziwara, Edna Teruko Kimura, Patricia Pereira Coltri
hnRNP A1 and hnRNP C associate with miR-17 and miR-18 in thyroid cancer cells. FEBS open bio 12 (6) (2022)
Cesar Seigi Fuziwara, Diego Claro de Mello, Edna Teruko Kimura
Gene Editing with CRISPR/Cas Methodology and Thyroid Cancer: Where Are We? Cancers 14 (3) (2022)
Daniel Casartelli de Santa-Inez, Cesar Seigi Fuziwara, Kelly Cristina Saito, Edna Teruko Kimura
Targeting the Highly Expressed microRNA miR-146b with CRISPR/Cas9n Gene Editing System in Thyroid Cancer. International journal of molecular sciences 22 (15) (2021)
Bin Xue, Chen-Hua Chuang, Haydn M Prosser, Cesar Seigi Fuziwara, Claudia Chan, Neil Sahasrabudhe, Maximilian Kühn, Yalei Wu, Jingqi Chen, Anne Biton, Caifu Chen, John Erby Wilkinson, Michael T McManus, Allan Bradley, Monte M Winslow, Bo Su, Lin He
miR-200 deficiency promotes lung cancer metastasis by activating Notch signaling in cancer-associated fibroblasts. Genes & development 35 (15-16) (2021)
Cesar Seigi Fuziwara, Kelly Cristina Saito, Edna Teruko Kimura
Interplay of TGFβ signaling and microRNA in thyroid cell loss of differentiation and cancer progression. Archives of endocrinology and metabolism 63 (5) (2019)
Lucas Goedert, Jessica Rodrigues Plaça, Cesar Seigi Fuziwara, Maiaro Cabral Rosa Machado, Desirée Rodrigues Plaça, Palloma Porto Almeida, Talita Perez Sanches, Jair Figueredo Dos Santos, Amanda Cristina Corveloni, Illy Enne Gomes Pereira, Marcela Motta de Castro, Edna Teruko Kimura, Wilson Araújo Silva, Enilza Maria Espreafico
Identification of Long Noncoding RNAs Deregulated in Papillary Thyroid Cancer and Correlated with BRAFV600E Mutation by Bioinformatics Integrative Analysis. Scientific reports 7 (1) (2017)

Cesar Seigi Fuziwara.css-eqlu8i{font-size:small;padding-left:4px;} (Cesar S Fuziwara)

Publication Activity (10 Years)

Top Topics

Top Venues

Cesar Seigi Fuziwara (Cesar S Fuziwara)